FERLAZZO, Edoardo
 Distribuzione geografica
Continente #
NA - Nord America 4.209
AS - Asia 3.424
EU - Europa 1.780
SA - Sud America 1.026
AF - Africa 72
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 9
Totale 10.538
Nazione #
US - Stati Uniti d'America 4.064
SG - Singapore 1.589
BR - Brasile 808
IT - Italia 720
CN - Cina 717
VN - Vietnam 478
IN - India 367
SE - Svezia 243
GB - Regno Unito 181
DE - Germania 178
EE - Estonia 128
AR - Argentina 102
CA - Canada 89
HK - Hong Kong 70
FI - Finlandia 66
UA - Ucraina 55
ID - Indonesia 47
MX - Messico 43
ZA - Sudafrica 40
RU - Federazione Russa 36
NL - Olanda 35
BD - Bangladesh 33
EC - Ecuador 33
TR - Turchia 23
CO - Colombia 22
FR - Francia 21
IQ - Iraq 20
ES - Italia 18
PY - Paraguay 18
AT - Austria 15
CL - Cile 15
JP - Giappone 15
PL - Polonia 15
AU - Australia 14
RO - Romania 14
CZ - Repubblica Ceca 11
PE - Perù 11
SA - Arabia Saudita 11
MA - Marocco 10
PK - Pakistan 8
UY - Uruguay 8
CH - Svizzera 7
GR - Grecia 7
IE - Irlanda 7
VE - Venezuela 7
A2 - ???statistics.table.value.countryCode.A2??? 6
EG - Egitto 5
IL - Israele 5
KZ - Kazakistan 5
JO - Giordania 4
TN - Tunisia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KE - Kenya 3
LT - Lituania 3
OM - Oman 3
RS - Serbia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
GA - Gabon 2
HN - Honduras 2
IR - Iran 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LV - Lettonia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PW - Palau 1
Totale 10.535
Città #
Dallas 749
Singapore 603
Chandler 544
Santa Clara 299
Bengaluru 298
Hefei 289
Milan 261
Princeton 218
Lawrence 217
Ho Chi Minh City 181
Chicago 141
Munich 141
Wilmington 135
Ashburn 133
London 129
Hanoi 97
Beijing 81
São Paulo 73
Des Moines 72
Hong Kong 70
Boardman 52
Ottawa 49
Los Angeles 44
Shanghai 42
Turku 39
Rome 35
New York 34
Catanzaro 32
Rio de Janeiro 30
Guangzhou 26
Helsinki 26
Haiphong 21
Seattle 19
Da Nang 18
Genoa 18
Redwood City 18
San Francisco 18
Johannesburg 17
Chennai 16
Norwalk 16
The Dalles 16
Thái Bình 15
Warsaw 15
Brooklyn 14
Mexico City 14
Naples 14
Stockholm 14
Atlanta 13
Bologna 13
Bắc Ninh 13
Charlotte 13
Pune 13
Quito 13
Columbus 12
Biên Hòa 11
Council Bluffs 11
Denver 11
Olomouc 11
Phoenix 11
Redmond 11
Boston 10
Brasília 10
Buenos Aires 10
Dhaka 10
Hải Dương 10
Jakarta 10
Tokyo 10
Toronto 10
Belo Horizonte 9
Guarulhos 9
Montreal 9
Ninh Bình 9
Salvador 9
Amsterdam 8
Assago 8
Cape Town 8
Guayaquil 8
San Nicola Manfredi 8
Shenzhen 8
Suzano 8
Ankara 7
Aracaju 7
Bogotá 7
Boydton 7
Cagliari 7
Can Tho 7
Casalnuovo Di Napoli 7
Curitiba 7
Gioia Tauro 7
Manaus 7
Manchester 7
Pelotas 7
Catania 6
Caxias do Sul 6
Dublin 6
Ferrara 6
Kemerovo 6
Lima 6
Montevideo 6
Porto Alegre 6
Totale 5.872
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 174
Genetics of reflex seizures and epilepsies in humans and animals 143
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 130
Epilessia occipitale con FOS in un paziente con calcificazioni cerebrali: studio clinico e video-EEG 129
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 122
A comprehensive machine-learning-based software pipeline to classify EEG signals: A case study on PNES vs. control subjects 111
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 97
A network analysis based approach to characterizing periodic sharp wave complexes in electroencephalograms of patients with sporadic CJD. 81
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 80
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 76
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 74
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 71
Lennox-Gastaut syndrome 70
About some behavioral and psychosocial aspects related to epilepsy. 69
Challenges in the pharmacological management of epilepsy and its causes in the elderly. 67
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 67
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 63
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 62
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 61
A commercially available device suppresses photic driving: implications for EEG recording. 61
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 59
A new Italian instrument for the assessment of irritability in patients with epilepsy. 58
Methodological issues associated with clinical trials in epilepsy 58
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 57
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 57
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. 56
Long-term outcome of mild mesial temporal lobe epilepsy 56
Absence status epilepsy: delineation of a distinct idiopathic generalized epilepsy syndrome. 54
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 53
Status epilepticus in pregnancy: a literature review and a protocol proposal 53
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 53
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 53
Familial idiopathic generalized epilepsy: description of an unusual phenotype in a family. 52
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. 52
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 51
Array-CGH in pazienti con epilessia e ritardo mentale 51
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy 51
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 51
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 50
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 50
Epidemiology and outcomes of status epilepticus 49
Epilepsy in “Sunflower syndrome”: electroclinical features, therapeutic response, and long-term follow-up 49
Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature 48
Therapeutic approach to neurological manifestations of Angelman syndrome 48
Gestural automatisms during syncope related to cervical malignancy 48
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 48
Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes 48
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 47
An educational campaign about epilepsy among Italian primary school teachers. 2. The results of a focused training program. 47
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 47
Dystonia in Angelman syndrome: a common, unrecognized clinical finding 47
When the practice does not meet the evidence: An Italian survey on the use of antiseizure medications in routine neurosurgery practice 46
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 46
Variable course of Unverricht-Lundborg disease 46
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy 46
Investigation into the casual or causal association of cerebral venous thrombosis and myelin oligodendrocyte glycoprotein antibody‑associated disease: A case report and literature review 45
Oxcarbazepine-related male infertility 45
Automated shape analysis improves the detection of hippocampal damage in patients with temporal lobe epilepsy 45
The journey of a floating fat: from suprasellar dermoid cyst to lateral ventricles 45
No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy. 45
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 45
Association of intronic variants of the KCNAB1 gene with lateral temporal epilepsy 44
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 44
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 44
Provocative techniques for functional/dissociative seizure: the colored pad test – a safe and reliable procedure 43
Rapid versus slow withdrawal of antiepileptic monotherapy in 2-year seizure-free adult patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study. 43
Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome 43
Transient edematous lesions of the splenium in epileptic patients 42
Lennox-GAstaut Syndrome in patients older than 40: clinical and EEG features 42
Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus 42
Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case-control study 41
Seizures When Exiting a Bath: A Rare Type of Reflex Epilepsy 41
Investigating Peri-Ictal MRI Abnormalities: A Prospective Neuroimaging Study on Status Epilepticus, Seizure Clusters, and Single Seizures 41
A Reappraisal on cortical myoclonus and brief Remarks on myoclonus of different Origins 41
Botulism-induced unilateral submandibular sialoadenitis: a case report. 41
Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study. 41
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 41
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 41
Neuro-anatomical differences among epileptic and non-epileptic déjà-vu. 41
Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study. 41
Diagnostic Biomarkers of Epilepsy 41
Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease 41
The hidden link between late-onset seizures and cerebral amyloid angiopathy: A case-control study 40
Alien hand syndrome-like functional seizures in a patient with right temporo-parietal damage and neurocognitive disorder: a case report 40
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 40
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 40
Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy. 40
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 40
Cerebral toxoplasmosis diagnosed by brain tissue PCR analysis in an immunocompetent patient 40
Information theoretic-based interpretation of a deep neural network approach in diagnosing psychogenic non-epileptic seizures 40
The Natural History of Epilepsy in 163 Untreated Patients: Looking for "Oligoepilepsy" 40
Peculiar clinical features of Lennox-Gastaut syndrome in trisomy 21 patients 40
Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis. 40
Effectiveness of Perampanel as the Only Add-on: Retrospective, Multicenter, Observational Real Life Study on epilepsy patients 39
Utility and limitations of homemade videos in differentiating functional seizures from other paroxysmal events: An Italian cohort study 39
Successful treatment of Holmes tremor by levetiracetam. 39
Alterations in the α2 δ ligand, thrombospondin-1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsies. 39
Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment 39
Patologia steno-occlusiva carotidea e sincope. Descrizione di un caso 39
Mutations in PRRT2 result in familial infantile seizures with heterogeneous phenotypes including febrile convulsions and probable SUDEP 39
Totale 5.455
Categoria #
all - tutte 113.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 19 18 8 18 96 10 1 6
2021/2022659 5 2 11 170 72 8 12 148 58 59 112 2
2022/20231.639 440 27 60 154 174 160 8 115 258 111 112 20
2023/2024809 146 113 71 61 54 162 33 33 22 22 25 67
2024/20253.151 404 253 154 136 152 418 101 86 356 268 279 544
2025/20264.203 312 697 1.132 1.433 629 0 0 0 0 0 0 0
Totale 10.817